Coming Soon
Men's Health is coming to REMEVi.
A dedicated men's health program — testosterone replacement therapy, ED treatment, and hair loss — is in development. It will arrive with the same fully bilingual, licensed clinical care REMEVi built its GLP-1 program on. Our GLP-1 weight loss program is open to men today.
- In development
- Bilingual care · EN + ES
Men's Health & Telehealth
Why men's health belongs online — and in your language.
Men consistently delay seeking healthcare. Research shows men are significantly less likely than women to pursue preventive care or to address symptoms like fatigue, low libido, or hair loss. The reasons are well documented: embarrassment, time constraints, and the friction of scheduling in-person appointments. Telehealth removes those barriers — a confidential evaluation from a phone or computer, a licensed provider's review, and discreet delivery with no pharmacy counter conversation.
For Spanish-speaking men, the gap is wider still. Most telehealth platforms operate in English only, leaving more than 30 million Spanish-speaking men in the US without care in the language they think and make health decisions in. REMEVi was built to close that gap. When the men's health program launches, every step — the intake, the clinical evaluation summary, medication instructions, and a dedicated care coordinator — will be available in fluent Spanish, not a machine translation.
That program is still in development. We chose to do one thing exceptionally well first: bilingual GLP-1 weight loss. Because body composition, energy, and testosterone are biologically linked, metabolic health is a natural foundation for the testosterone and performance goals a men's health program supports. If weight is part of your picture, you do not have to wait — REMEVi's GLP-1 program is open to men in all 50 states plus DC today.
What's Coming
What REMEVi Men's Health will cover.
A look at the conditions the program is being built to treat — with the bilingual, licensed clinical care REMEVi is known for.
Low Testosterone (Low T)
Low testosterone affects an estimated 2–6 million US men, yet the majority go undiagnosed. Symptoms include fatigue, reduced muscle mass, low libido, mood changes, and difficulty concentrating. A simple blood test confirms whether levels are clinically low and, when appropriate, guides a treatment protocol overseen by a licensed provider.
Erectile Dysfunction (ED)
ED affects roughly 30 million American men. It is common, treatable, and nothing to be embarrassed about. Standard options include sildenafil, tadalafil, and compounded formulations. Because ED can be an early signal of cardiovascular or hormonal conditions, a thorough provider review matters as much as the prescription itself.
Male Pattern Hair Loss
Male pattern baldness affects roughly half of men by age 50. The most effective treatments — finasteride and minoxidil — work best when started early. Both oral and topical formulations exist, and a licensed provider tailors the approach to the pattern and stage of hair loss.
Weight & Metabolic Health
Body composition, energy, and testosterone are deeply linked. Carrying excess weight can suppress testosterone, while sustainable fat loss often improves it. This is why metabolic health is a natural starting point — and why REMEVi’s GLP-1 weight loss program is available to men today, ahead of the broader men’s health launch.
Informational only. The men's health program is not yet available for enrollment. Compounded and prescription medications require evaluation by a licensed provider; individual results vary.
FAQ
Men's health questions answered
REMEVi is preparing to add a dedicated men’s health program — covering testosterone replacement therapy, erectile dysfunction treatment, and hair loss — in the months ahead. We are focused first on delivering an exceptional bilingual GLP-1 weight loss experience, and will expand into men’s health once that foundation is firmly established. This page will be updated the moment enrollment opens.
TRT restores testosterone to a healthy range in men with clinically low levels, a condition called hypogonadism. It can be delivered as injections, topical gels, or pellets. When prescribed and monitored by a licensed provider — with baseline and follow-up lab work — TRT has a well-established safety profile. Common symptoms of low testosterone include fatigue, low libido, difficulty building muscle, mood changes, and brain fog.
Erectile dysfunction is common and highly treatable. First-line options include PDE5 inhibitors such as sildenafil and tadalafil, available in standard and compounded formulations. Because ED can sometimes signal an underlying cardiovascular or hormonal issue, a licensed provider should review your full health history before any treatment is considered.
For male pattern hair loss (androgenetic alopecia), finasteride and minoxidil are the two treatments with the strongest clinical evidence. They work best when started early, before significant follicle loss. Oral and topical formulations both exist, and results typically take three to six months of consistent use to become visible.
Yes. Fully bilingual English and Spanish care is core to everything REMEVi builds. When the men’s health program launches, the intake, the clinical evaluation, medication instructions, and your care coordinator will all be available in Spanish — exactly as they are for the REMEVi GLP-1 weight loss program today.
REMEVi’s GLP-1 weight loss program is open today. It pairs compounded semaglutide or tirzepatide with licensed US providers, included care coaching, and bilingual support in all 50 states plus DC. Many men begin with weight management, and metabolic health is often the foundation for the testosterone, energy, and body-composition goals that a men’s health program later supports.
Available Now
Start with GLP-1 weight loss.
Compounded semaglutide or tirzepatide, licensed US providers, included care coaching — bilingual, in all 50 states plus DC.
Explore the GLP-1 Program